Skip to main content

Table 4 Comparison of lymphocyte count, lymphocyte subsets, and dendritic cells before and after treatment with carbidopa in the experimental group(x ± s)

From: Effect of immune-modulating metronomic capecitabine as an adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma

Group

Lymphocyte count

CD4+

CD8+

CD28 + CD4+

Activated CD4+

CD28 + CD8+

Activated CD8+

CD4/CD8 ratio

CD3+

PDCs

MDCs

Before treatment

1.70 × 109±0.14 × 109

33.08 ± 3.73

21.97 ± 1.81

31.78 ± 4.25

3.73 ± 0.79

12.52 ± 0.85

3.96 ± 0.88

1.53 ± 0.20

60.91 ± 3.75

2.14 ± 0.040

8.36 ± 2.21

After

treatment

1.48 × 109±0.15 × 109

23.11 ± 1.71

24.22 ± 3.13

20.20 ± 2.04

3.14 ± 0.64

11.38 ± 1.12

5.85 ± 1.50

1.14 ± 0.17

52.04 ± 3.64

2.20 ± 0.54

5.79 ± 1.18

t

1.171

3.48

-1.049

3.725

0.694

1.080

-1.281

3.34

1.992

-1.121

1.78

P

0.263

0.006

0.319

0.004

0.504

0.306

0.229

0.007

0.074

0.906

0.263